The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis

BACKGROUND: Until now, there is no effective anti-fibrotic therapy available for liver cirrhosis. Stem cell therapies have been studied for the treatment of hepatic fibrosis. However, the use of embryonic stem cells or induced pluripotent stem cells (iPSC) has limitations such as ethical concern or...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Suhyun, In Hwang, Seon, Kim, Jonghun, Hwang, Seoyeon, Kang, Sohee, Yang, Sera, Kim, Jonghwa, Kang, Wonseok, Kim, Kyun-Hwan, Han, Dong Wook, Paik, Yong-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330392/
https://www.ncbi.nlm.nih.gov/pubmed/30635054
http://dx.doi.org/10.1186/s13287-018-1127-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330392/
https://www.ncbi.nlm.nih.gov/pubmed/30635054
http://dx.doi.org/10.1186/s13287-018-1127-3

Ejemplares similares